Vistra Fights PFAS Testing After Battery Fire
Liquidia Drug Approved As Rival United Throws Hail Mary To Delay Actual Launch
Amid a vicious legal dispute, Liquidia ($LQDA) finally won FDA approval on May 23 for its medicine Yutrepia to treat two deadly lung diseases: PAH and PH-ILD. But a federal judge could still block Yutrepia from actually launching on time, due to new litigation filed by United Therapeutics ($UTHR) to delay competition against its incumbent drug Tyvaso.
EU Restricts Public Access to Satellite Imagery Over Red Sea
BREAKING: Debris and Missing Wildlife in Nature Reserve After Vistra Battery Fire
Massive American Military Deployment To Middle East With Yemen Conflict Intensifying
Fatal Accident at Universal Stainless Leads Steelworkers To Flag Ongoing Safety Failures
Cartel Crackdown Could Hit Remitly and Western Union
BREAKING: County Silences Reporters as Vistra Dodges Questions About Surface Testing; Later Reverses Course
There’s No New Coronavirus (Just Viral Clickbait)
BREAKING: Vistra Fire Reignites, No Evacuation Ordered
BREAKING: New Data Indicates Elevated Heavy Metal After Vistra Fire
Can The EV Charging Business Survive the Trump Administration?
BREAKING: As PDD Hit by Tariffs, Companies Enabling Chinese Surveillance Remain Nasdaq Listed
BREAKING: VISTRA FIRE DAMAGE CONTROL LED BY FOSSIL FUEL CRISIS FIRM
It seems their best idea is $750 gift cards that residents have called a “joke” and “insult.”
BREAKING: After Vistra Fire, Residents Report Illness, Scientists Confirm Contaminated Soil
CHINA’S DJI, WORLD’S LARGEST DRONE MANUFACTURER, NO LONGER BLOCKS FLIGHTS OVER AIRPORTS AND MILITARY BASES
Plug Power Appears on Verge of Closing Critical DOE Loan, a Lifeline for the Cash-Strapped Hydrogen Company, Based on DOE Website Change
Hims: Why The Semaglutide Shortage May End Imminently
BioAge: Too Young To Die?
Hims: Is Tomorrow the End of the GLP-1 Shortage?
Cracking Big Egg: Why the Industry’s Narrative Doesn’t Add Up
RH: Where Did All The Cash Go?
Schrödinger: The Nvidia Biotech Partner Jensen Huang Told To “Think Bigger”
FDA Heads to Court to Defend Unprecedented Decision Protecting Lung Drug Monopoly From Liquidia Competition
Plug Power Failure Part II: Is Plug The Next Solyndra? Accounting Analysis Reveals Dwindling Cash, Collapse of Margins, And Unprofitable Fuel Deliveries, Indicating Company May Not Be Able To Pay Back The DOE
Plug Power Failure Part I: Critical DOE Loan at Risk Due To False Water Data, Cash Crunch, And Stalled Expansions As Hostile Trump Administration Looms
Universal Stainless, Set To Be Acquired, Behind Fatal Bell Boeing Osprey Crash
“WE’VE GOT A LOT OF PEOPLE KILLED HERE”
ESSENTIAL NODE IN GLOBAL SEMICONDUCTOR SUPPLY CHAIN HIT BY HURRICANE HELENE — COMPANY SAYS IT HAS “TEMPORARILY HALTED OPERATIONS” AFTER VIDEO REVEALS ENTRANCE TO MINE HAS FLOODED
CAVA: FILTH FLIES, “C” SANITATION GRADES, FDA LISTERIA SWABS, SNEAKY SEED OIL, INSIDER SELLING, AND THE DIARRHETIC FALLOUT OF FAST GROWTH
“Grand Deception” — Winnebago Muzzles Outcry Over Major Problem That Owners Say Makes RVs Dangerous, Untowable, Worthless
The Struggling AI Bet Behind Softbank’s Grocery Gamble
Coal, Crypto, and False Branding: Inside TeraWulf’s Greenwashing Machine
Fission Impossible: Nano Nuclear Has No Revenue, No Products, “Laughable” Timelines, Part-Time Executives, and a $600 Million Market Cap
Hims & Hers Selling GLP-1 Injection That’s Not FDA Approved, From Shady Supplier — And Won’t Make You Talk to a Doctor to Get It
Timber Certifier Endangers Amazonian Tribe, Warn Activists and Locals
Forensic Report: Arcadium Lithium ($ALTM) Merger Results and Accounting Raise Red Flags
Arcadium Lithium: Drying Argentina’s Andes to Power EVs
How We Crunched The Numbers Behind The Arcadium Investigation
ADM IN RUSSIA
U.S. AGRIBUSINESS PARTNERED WITH GRAIN GIANT SUSPECTED OF STEALING UKRAINIAN RESOURCES
Free Newsletter Sign Up
Breaking News & Investigations.
Right to Your Inbox.
No Paywalls.
No Ads.